REPL / Replimune Group, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Replimune Group, Inc.
US ˙ NasdaqGS ˙ US76029N1063

Ausstehende Aktien 82,572,619 shares
Insider-Aktien44.069.749 shares
Insider-Besitz53,37 %
Insider gesamt43
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

-6 ( )
10716 out of 10951

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

-0.171% ( )
10258 out of 10791

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

Replimune Group, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Atlas Venture Associates X, L.p. 10% Owner - [10%] 4.453.386 4.453.386
Philip Astley-Sparke Director - [D] 1.412.414 1.412.414
Atlas Venture Associates Opportunity I, L.P. - 2.200.000 2.200.000
Atlas Venture Associates Opportunity I, LLC - 2.200.000 2.200.000
Atlas Venture Associates X, LLC 10% Owner - [10%] 4.453.386 4.453.386
Atlas Venture Fund X, L.P. 10% Owner - [10%] 2.486.296 2.486.296
Atlas Venture Opportunity Fund I, L.P. - 2.200.000 2.200.000
Baker Bros. Advisors Lp Director, 10% Owner - [D] [10%] 10.116.095 10.116.095
BCIP Life Sciences Associates, LP 10% Owner - [10%] 2.838.968 2.838.968
Bain Capital Life Sciences Fund, L.P. 10% Owner - [10%] 2.838.968 2.838.968
Bain Capital Life Sciences Investors, LLC 10% Owner - [10%] 2.838.968 2.838.968
Bain Capital Life Sciences Partners, LP 10% Owner - [10%] 2.838.968 2.838.968
Robert Coffin Director - [D] 1.821.872 1.821.872
Kapil Dhingra Director - [D] 0 0
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Pamela Esposito Chief Business Officer - [O] 263.436 263.436
Forbion Capital Fund III Cooperatief U.A. 10% Owner - [10%] 4.721.449 4.721.449
Franchi Jean M. Chief Financial Officer - [O] 128.748 128.748
Stephen A Gorgol 66.050
Jeremy Green 10% Owner - [10%] 779.655 779.655
Emily Luisa Hill Chief Financial Officer - [O] 236.556 236.556
Howard Kaufman Chief Medical Officer - [O] 58.067 58.067
Adam Koppel 10% Owner - [10%] 2.838.968 2.838.968
Hyam Levitsky 16.500
Tanya Lewis Chief Dev. Op. Officer - [O] 135.293 135.293
Lim Richard J. 10% Owner - [10%] 13.500 4.854.783
Colin Love Chief Operating Officer - [O] 777.345 777.345
Oliger Christy J. 16.500
Omega Fund IV G.P. Manager, Ltd. 10% Owner - [10%] 4.763.380 4.673.380
Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst
Omega Fund IV GP, L.P. 10% Owner - [10%] 4.763.380 4.673.380
Omega Fund IV, L.P. 10% Owner - [10%] 4.673.380 4.673.380
Sushil Patel Chief Executive Officer, Director - [D] [O] 747.492 747.492
Andrea Pirzkall Chief Medical Officer - [O] 21.500 21.500
Paolo Pucci 16.500
Redmile Group, LLC 10% Owner - [10%] 779.655 779.655
Jason P Rhodes Director - [D] 946.000 946.000
Joseph P Slattery Director - [D] 6.667 6.667
Christopher Sarchi Chief Commercial Officer - [O] 180.962 180.962
Jeffrey Lawrence Schwartz 10% Owner - [10%] 2.838.968 2.838.968
Andrew Schwendenman Chief Accounting Officer - [O] 107.057 107.057
Hugo Alexander Slootweg Director, 10% Owner - [D] [10%] 4.721.449 4.721.449
Otello Stampacchia Director, 10% Owner - [D] [10%] 16.500 4.673.380
Dieter Weinand 24.750
Konstantinos Xynos Chief Medical Officer - [O] 235.662 235.662

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in REPL / Replimune Group, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2019-11-18 Omega Fund IV, L.P. 220.000 13,6100 220.000 13,6100 2.994.200 365 48.9100 7.766.000 259,37
2019-11-18 Rhodes Jason P 1.100.000 13,6100 1.100.000 13,6100 14.971.000
2018-07-24 Omega Fund IV, L.P. 266.667 15,0000 266.667 15,0000 4.000.005
2018-07-24 Bain Capital Life Sciences Investors, LLC 500.000 15,0000 500.000 15,0000 7.500.000
2018-07-24 Forbion Capital Fund III Cooperatief U.A. 133.333 15,0000 133.333 15,0000 1.999.995
2018-07-24 SLATTERY JOSEPH P 6.667 15,0000 6.667 15,0000 100.005

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

REPL / Replimune Group, Inc. Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in REPL / Replimune Group, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2026-05-18 Xynos Konstantinos 14.023 5,0800 14.023 5,0800 71.237 8 4.6000 -6.730 -9,45
2026-05-18 Schwendenman Andrew 7.894 5,0800 7.894 5,0800 40.102
2026-05-18 Sarchi Christopher 8.626 5,0800 8.626 5,0800 43.820
2026-05-18 Astley-Sparke Philip 17.657 5,0800 17.657 5,0800 89.698
2026-05-18 Patel Sushil 37.324 5,0800 37.324 5,0800 189.606
2026-05-18 Hill Emily Luisa 7.812 5,0800 7.812 5,0800 39.685
2025-12-09 Dhingra Kapil 3.169 10,4000 3.169 10,4000 32.958
2025-11-17 Sarchi Christopher 5.208 9,1000 5.208 9,1000 47.393
2025-11-17 Xynos Konstantinos 7.248 9,1000 7.248 9,1000 65.957

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

REPL / Replimune Group, Inc. Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2026-06-03 2026-06-01 4 Sarchi Christopher REPL Common Stock S - Sale D 9,2400 -12.000 -111 180.962
2026-05-20 2026-05-18 4 Hill Emily Luisa REPL Common Stock S - Sale D 5,0800 -7.812 -40 236.556
2026-05-20 2026-05-18 4 Patel Sushil REPL Common Stock S - Sale D 5,0800 -37.324 -190 747.492
2026-05-20 2026-05-18 4 Astley-Sparke Philip REPL Common Stock S - Sale D 5,0800 -17.657 -90 1.412.414
2026-05-20 2026-05-18 4 Sarchi Christopher REPL Common Stock S - Sale D 5,0800 -8.626 -44 192.962
2026-05-20 2026-05-18 4 Schwendenman Andrew REPL Common Stock S - Sale D 5,0800 -7.894 -40 107.057
2026-05-20 2026-05-18 4 Xynos Konstantinos REPL Common Stock S - Sale D 5,0800 -14.023 -71 235.662
2026-04-07 2026-04-01 4 Sarchi Christopher REPL Common Stock A - Award D 50.000 201.588
2026-04-07 2026-04-01 4 Astley-Sparke Philip REPL Common Stock A - Award D 50.000 1.430.071
2026-04-07 2026-04-01 4 Schwendenman Andrew REPL Common Stock A - Award D -36.667 114.951
2026-04-07 2026-04-01 4 Xynos Konstantinos REPL Common Stock A - Award D 50.000 249.685
2026-04-07 2026-04-01 4 Patel Sushil REPL Common Stock A - Award D 251.240 784.816
2026-04-07 2026-04-01 4 Hill Emily Luisa REPL Common Stock A - Award D 50.000 244.368
2026-04-06 2026-04-02 4 Sarchi Christopher REPL Common Stock S - Sale D 8,0100 -6.500 -52 151.588
2026-02-20 2026-02-18 4 Astley-Sparke Philip REPL Common Stock G - Gift D -25.000 1.380.071
2025-12-19 2025-12-19 4 Patel Sushil REPL Common Stock A - Award D 200.000 533.576
2025-12-19 2025-12-19 4 Xynos Konstantinos REPL Common Stock A - Award D 60.000 199.685
2025-12-19 2025-12-19 4 Hill Emily Luisa REPL Common Stock A - Award D 60.000 194.368
2025-12-19 2025-12-19 4 Sarchi Christopher REPL Common Stock A - Award D 35.000 158.088
2025-12-19 2025-12-19 4 Schwendenman Andrew REPL Common Stock A - Award D 10.000 78.284
2025-12-11 2025-12-09 4 Dhingra Kapil REPL Common Stock S - Sale D 10,4000 -3.169 -33 0
2025-12-11 2025-12-09 4 Dhingra Kapil REPL Common Stock M - Exercise D 1,7500 3.169 6 3.169
2025-12-04 2025-12-02 4 Patel Sushil REPL Common Stock S - Sale D 11,1300 -10.000 -111 333.576
2025-11-19 2025-11-17 4 Sarchi Christopher REPL Common Stock S - Sale D 9,1000 -5.208 -47 123.088
2025-11-19 2025-11-17 4 Xynos Konstantinos REPL Common Stock S - Sale D 9,1000 -7.248 -66 139.685
2025-08-19 2025-08-15 4 Hill Emily Luisa REPL Common Stock S - Sale D 5,3700 -9.154 -49 134.368
2025-05-22 2025-05-20 4 Astley-Sparke Philip REPL Common Stock S - Sale D 8,0600 -32.279 -260 1.405.071
2025-05-22 2025-05-20 4 Xynos Konstantinos REPL Common Stock S - Sale D 8,0600 -7.952 -64 146.933
2025-05-22 2025-05-20 4 Patel Sushil REPL Common Stock S - Sale D 8,0600 -25.105 -202 343.576
2025-05-22 2025-05-20 4 Schwendenman Andrew REPL Common Stock S - Sale D 8,0500 -3.287 -26 68.284
2025-05-22 2025-05-20 4 Hill Emily Luisa REPL Common Stock S - Sale D 8,0500 -2.535 -20 143.522
2025-05-22 2025-05-20 4 Sarchi Christopher REPL Common Stock S - Sale D 8,0500 -3.749 -30 128.296
2025-04-03 2025-04-01 4 Patel Sushil REPL Common Stock A - Award D 166.667 368.681
2025-04-03 2025-04-01 4 Xynos Konstantinos REPL Common Stock A - Award D 45.000 154.885
2025-04-03 2025-04-01 4 Hill Emily Luisa REPL Common Stock A - Award D 45.000 146.057
2025-04-03 2025-04-01 4 Sarchi Christopher REPL Common Stock A - Award D 45.000 132.045
2025-04-03 2025-04-01 4 Schwendenman Andrew REPL Common Stock A - Award D -33.333 71.571
2025-03-07 3 BAKER BROS. ADVISORS LP See Footnotes REPL Common Stock I 10.116.095
2025-03-07 3 BAKER BROS. ADVISORS LP See Footnotes REPL Common Stock I 929.241
2024-12-18 2024-12-16 4 Patel Sushil REPL Common Stock S - Sale D 12,4200 -10.000 -124 202.014
2024-11-20 2024-11-18 4 Xynos Konstantinos REPL Common Stock S - Sale D 10,7800 -7.246 -78 109.885
2024-11-20 2024-11-18 4 Sarchi Christopher REPL Common Stock S - Sale D 10,7800 -5.207 -56 87.045
2024-08-30 2024-08-30 4 Astley-Sparke Philip REPL Common Stock G - Gift D -50.000 1.437.350
2024-08-19 2024-08-16 4 Hill Emily Luisa REPL Common Stock S - Sale D 10,1800 -8.938 -91 101.057
2024-06-10 2024-06-07 4 Xynos Konstantinos REPL Common Stock S - Sale D 7,5000 -15.881 -119 117.131
2024-05-20 2024-05-16 4 Sarchi Christopher REPL Common Stock S - Sale D 6,4700 -2.218 -14 92.252
2024-05-20 2024-05-16 4 Schwendenman Andrew REPL Common Stock S - Sale D 6,4700 -2.298 -15 38.238
2024-05-20 2024-05-16 4 Love Colin REPL Common Stock S - Sale D 6,4700 -17.615 -114 777.345
2024-05-20 2024-05-16 4 Astley-Sparke Philip REPL Common Stock S - Sale D 6,4700 -37.928 -245 1.487.350
2024-05-20 2024-05-16 4 Coffin Robert REPL Common Stock S - Sale D 6,4700 -11.464 -74 1.821.872
2024-05-20 2024-05-16 4 Patel Sushil REPL Common Stock S - Sale D 6,4700 -20.194 -131 212.014
2024-05-20 2024-05-16 4 Xynos Konstantinos REPL Common Stock S - Sale D 6,4700 -6.367 -41 133.012
2024-04-03 2024-04-01 4 Patel Sushil REPL Common Stock A - Award D 83.335 232.208
2024-04-03 2024-04-01 4 Xynos Konstantinos REPL Common Stock A - Award D 26.665 139.379
2024-04-03 2024-04-01 4 Schwendenman Andrew REPL Common Stock A - Award D 17.775 40.536
2024-04-03 2024-04-01 4 Sarchi Christopher REPL Common Stock A - Award D 22.225 94.470
2024-04-03 2024-04-01 4 Hill Emily Luisa REPL Common Stock A - Award D 26.665 109.995
2023-11-17 2023-11-16 4 Sarchi Christopher REPL Common Stock S - Sale D 10,9200 -5.255 -57 72.245
2023-11-17 2023-11-16 4 Xynos Konstantinos REPL Common Stock S - Sale D 10,9200 -7.313 -80 112.714
2023-09-20 2023-09-18 4 Hill Emily Luisa REPL Common Stock A - Award D 83.330 83.330
2023-09-13 2023-09-12 4 Esposito Pamela REPL Common Stock S - Sale D 20,0000 -300 -6 263.436
2023-09-13 2023-09-12 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 300 1 263.736
2023-09-13 2023-09-11 4 Esposito Pamela REPL Common Stock S - Sale D 20,0100 -5.358 -107 263.436
2023-09-13 2023-09-11 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 5.358 18 268.794
2023-08-24 2023-08-22 4 Esposito Pamela REPL Common Stock S - Sale D 20,0100 -18.600 -372 263.436
2023-08-24 2023-08-22 4 Esposito Pamela REPL Common Stock M - Exercise D 15,5000 5.000 78 282.036
2023-08-24 2023-08-22 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 13.600 45 277.036
2023-08-15 2023-08-11 4 Esposito Pamela REPL Common Stock S - Sale D 20,0000 -1.400 -28 263.436
2023-08-15 2023-08-11 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 1.400 5 264.836
2023-07-26 3 Sarchi Christopher REPL Common Stock D 22.500
2023-07-26 3 Sarchi Christopher REPL Common Stock D 55.000
2023-07-11 2023-07-10 4 Esposito Pamela REPL Common Stock S - Sale D 21,1200 -2.077 -44 263.436
2023-07-11 2023-07-10 4 Esposito Pamela REPL Common Stock S - Sale D 21,6300 -17.923 -388 265.513
2023-07-11 2023-07-10 4 Esposito Pamela REPL Common Stock M - Exercise D 15,5000 5.000 78 283.436
2023-07-11 2023-07-10 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 15.000 50 278.436
2023-06-15 2023-06-13 4 Lewis Tanya REPL Common Stock S - Sale D 23,4500 -817 -19 135.293
2023-06-15 2023-06-13 4 Lewis Tanya REPL Common Stock S - Sale D 24,1000 -12.043 -290 136.110
2023-06-15 2023-06-13 4 Patel Sushil REPL Common Stock S - Sale D 23,4400 -553 -13 148.873
2023-06-15 2023-06-13 4 Patel Sushil REPL Common Stock S - Sale D 24,1100 -5.145 -124 149.426
2023-05-18 3 Schwendenman Andrew REPL Common Stock D 22.761
2023-05-18 2023-05-16 4 Coffin Robert REPL Common Stock S - Sale D 18,0500 -7.861 -142 1.833.336
2023-05-18 2023-05-16 4 Patel Sushil REPL Common Stock S - Sale D 18,0500 -15.575 -281 154.571
2023-05-18 2023-05-16 4 Lewis Tanya REPL Common Stock S - Sale D 18,0500 -12.207 -220 148.153
2023-05-18 2023-05-16 4 Franchi Jean M. REPL Common Stock S - Sale D 18,0500 -11.351 -205 128.748
2023-05-18 2023-05-16 4 Love Colin REPL Common Stock S - Sale D 18,0500 -10.775 -194 794.960
2023-05-18 2023-05-16 4 Xynos Konstantinos REPL Common Stock S - Sale D 18,0500 -771 -14 120.027
2023-05-18 2023-05-16 4 Esposito Pamela REPL Common Stock S - Sale D 18,0500 -5.966 -108 263.436
2023-05-18 2023-05-16 4 Astley-Sparke Philip REPL Common Stock S - Sale D 18,0500 -17.902 -323 1.525.278
2023-04-04 2023-04-01 4 Xynos Konstantinos REPL Common Stock A - Award D 50.000 120.798
2023-04-04 2023-04-01 4 Esposito Pamela REPL Common Stock A - Award D 40.000 269.402
2023-04-04 2023-04-01 4 Coffin Robert REPL Common Stock A - Award D 45.000 1.841.197
2023-04-04 2023-04-01 4 Lewis Tanya REPL Common Stock A - Award D 40.000 160.360
2023-04-04 2023-04-01 4 Patel Sushil REPL Common Stock A - Award D 40.000 170.146
2023-04-04 2023-04-01 4 Astley-Sparke Philip REPL Common Stock A - Award D 142.100 1.543.180
2023-04-04 2023-04-01 4 Love Colin REPL Common Stock A - Award D 40.000 805.735
2023-04-04 2023-04-01 4 Franchi Jean M. REPL Common Stock A - Award D 45.000 140.099
2022-12-13 2022-12-09 4 Esposito Pamela REPL Common Stock S - Sale D 25,0300 -15.000 -375 229.402
2022-12-13 2022-12-09 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 15.000 15 244.402
2022-12-05 2022-12-01 4 Xynos Konstantinos REPL Common Stock A - Award D 17.500 70.798
2022-12-05 3 Xynos Konstantinos REPL Common Stock D 37.500
2022-12-05 3 Xynos Konstantinos REPL Common Stock D 8.798
2022-12-05 3 Xynos Konstantinos REPL Common Stock D 7.000
2022-05-18 2022-05-16 4 Love Colin REPL Common Stock S - Sale D 14,5900 -6.324 -92 765.735
2022-05-18 2022-05-16 4 Franchi Jean M. REPL Common Stock S - Sale D 14,5900 -3.436 -50 95.099
2022-05-18 2022-05-16 4 Esposito Pamela REPL Common Stock S - Sale D 14,5900 -3.507 -51 229.402
2022-05-18 2022-05-16 4 Lewis Tanya REPL Common Stock S - Sale D 14,5900 -5.473 -80 120.360
2022-05-18 2022-05-16 4 Patel Sushil REPL Common Stock S - Sale D 14,5900 -10.687 -156 130.146
2022-05-18 2022-05-16 4 Coffin Robert REPL Common Stock S - Sale D 14,5900 -5.737 -84 1.796.197
2022-05-18 2022-05-16 4 Astley-Sparke Philip REPL Common Stock S - Sale D 14,5900 -9.632 -141 1.401.080
2022-04-05 2022-04-01 4 Coffin Robert REPL Employee Stock Option (right to buy) A - Award D 18,26 39.375 39.375
2022-04-05 2022-04-01 4 Coffin Robert REPL Common Stock A - Award D 26.250 1.801.934
2022-04-05 2022-04-01 4 Franchi Jean M. REPL Employee Stock Option (right to buy) A - Award D 18,26 78.750 78.750
2022-04-05 2022-04-01 4 Franchi Jean M. REPL Common Stock A - Award D 52.500 98.535
2022-04-05 2022-04-01 4 Astley-Sparke Philip REPL Employee Stock Option (right to buy) A - Award D 18,26 105.000 105.000
2022-04-05 2022-04-01 4 Astley-Sparke Philip REPL Common Stock A - Award D 70.000 1.410.712
2022-04-05 2022-04-01 4 Patel Sushil REPL Employee Stock Option (right to buy) A - Award D 18,26 78.750 78.750
2022-04-05 2022-04-01 4 Patel Sushil REPL Common Stock A - Award D 52.500 140.833
2022-04-05 2022-04-01 4 Lewis Tanya REPL Employee Stock Option (right to buy) A - Award D 18,26 78.750 78.750
2022-04-05 2022-04-01 4 Lewis Tanya REPL Common Stock A - Award D 52.500 125.833
2022-04-05 2022-04-01 4 Esposito Pamela REPL Employee Stock Option (right to buy) A - Award D 18,26 34.125 34.125
2022-04-05 2022-04-01 4 Esposito Pamela REPL Common Stock A - Award D 22.750 232.909
2022-04-05 2022-04-01 4 Rhodes Jason P REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Love Colin REPL Employee Stock Option (right to buy) A - Award D 18,26 39.375 39.375
2022-04-05 2022-04-01 4 Love Colin REPL Common Stock A - Award D 26.250 772.059
2022-04-05 2022-04-01 4 Dhingra Kapil REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Slootweg Hugo Alexander REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Weinand Dieter REPL Stock Option (right to buy) A - Award D 18,26 24.750 24.750
2022-04-05 2022-04-01 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Pucci Paolo REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Oliger Christy J. REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-04-05 2022-04-01 4 Levitsky Hyam REPL Stock Option (right to buy) A - Award D 18,26 16.500 16.500
2022-03-16 2022-03-16 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 15,5500 -38.762 -603 4.673.380
2022-03-16 2022-03-16 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 15,3100 -6.238 -96 4.712.142
2022-03-16 2022-03-15 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 15,6400 -45.000 -704 4.718.380
2022-03-16 2022-03-14 4 Omega Fund IV, L.P. By Otello Stampacchia REPL Non-Qualified Stock Options M - Exercise I 9,78 -16.500 16.500
2022-03-16 2022-03-14 4 Omega Fund IV, L.P. By Otello Stampacchia REPL Common Stock S - Sale I 15,4200 -16.500 -254 4.763.380
2022-03-16 2022-03-14 4 Omega Fund IV, L.P. By Otello Stampacchia REPL Common Stock M - Exercise I 9,7800 16.500 161 4.779.880
2021-12-03 2021-12-01 4 Oliger Christy J. REPL Stock Option (right to buy) A - Award D 28,01 33.000 33.000
2021-11-23 2021-11-22 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 34,7000 -10.162 -353 4.763.380
2021-11-23 2021-11-19 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 34,8000 -417 -15 4.773.542
2021-11-23 2021-11-19 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 34,5400 -34.845 -1.204 4.773.959
2021-11-18 2021-11-18 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -2.441 -82 4.808.804
2021-11-18 2021-11-16 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -153 -5 4.811.245
2021-11-18 2021-11-18 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -2.441 -82 4.808.804
2021-11-18 2021-11-16 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -153 -5 4.811.245
2021-11-16 2021-11-15 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,6600 -782 -26 4.811.398
2021-11-16 2021-11-12 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,6600 -23.235 -782 4.812.180
2021-11-12 2021-11-11 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,6100 -18.279 -614 4.835.415
2021-11-12 2021-11-10 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -11 -0 4.853.694
2021-11-10 2021-11-09 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,7300 -7.537 -254 4.853.705
2021-11-10 2021-11-08 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5300 -3.817 -128 4.861.242
2021-11-08 2021-11-05 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5000 -5.790 -194 4.865.059
2021-11-08 2021-11-04 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5800 -25.225 -847 4.870.849
2021-10-19 2021-10-18 4 Love Colin REPL Common Stock S - Sale D 29,5800 -12.711 -376 745.809
2021-10-19 2021-10-15 4 Love Colin REPL Common Stock S - Sale D 30,3100 -15.089 -457 758.520
2021-10-19 2021-10-15 4 Love Colin REPL Common Stock S - Sale D 31,1600 -2.200 -69 773.609
2021-09-27 2021-09-23 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,5800 -12.171 -409 4.896.074
2021-09-20 2021-09-17 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 33,7100 -15.465 -521 4.908.245
2021-09-20 2021-09-17 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 32,8800 -78.998 -2.597 4.923.710
2021-09-20 2021-09-16 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 32,5500 -5.537 -180 5.002.708
2021-09-17 2021-09-15 4 Love Colin REPL Common Stock S - Sale D 31,2300 -30.000 -937 775.809
2021-08-18 2021-08-16 4 Love Colin REPL Common Stock S - Sale D 29,2700 -2.700 -79 805.809
2021-08-18 2021-08-16 4 Love Colin REPL Common Stock S - Sale D 30,0000 -27.300 -819 808.509
2021-08-06 2021-08-05 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 15,50 -25.800 45.750
2021-08-06 2021-08-05 4 Esposito Pamela REPL Common Stock S - Sale D 35,0900 -25.800 -905 210.159
2021-08-06 2021-08-05 4 Esposito Pamela REPL Common Stock M - Exercise D 15,5000 25.800 400 235.959
2021-08-06 2021-08-04 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 15,50 -4.200 71.550
2021-08-06 2021-08-04 4 Esposito Pamela REPL Common Stock S - Sale D 35,0000 -4.200 -147 210.159
2021-08-06 2021-08-04 4 Esposito Pamela REPL Common Stock M - Exercise D 15,5000 4.200 65 214.359
2021-07-22 2021-07-21 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -12.538 51.203
2021-07-22 2021-07-21 4 Esposito Pamela REPL Common Stock S - Sale D 33,1700 -12.538 -416 210.159
2021-07-22 2021-07-21 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 12.538 13 222.697
2021-07-22 2021-07-20 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -4.862 63.741
2021-07-22 2021-07-20 4 Esposito Pamela REPL Common Stock S - Sale D 33,0500 -4.862 -161 210.159
2021-07-22 2021-07-20 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 4.862 5 215.021
2021-07-19 2021-01-19 4/A Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -5.727 73.203
2021-07-19 2021-01-19 4/A Esposito Pamela REPL Common Stock S - Sale D 42,3800 -5.127 -217 175.994
2021-07-19 2021-01-19 4/A Esposito Pamela REPL Common Stock S - Sale D 43,2400 -600 -26 181.121
2021-07-19 2021-01-19 4/A Esposito Pamela REPL Common Stock M - Exercise D 1,0100 5.727 6 181.721
2021-07-19 2021-01-15 4/A Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -29.273 78.930
2021-07-19 2021-01-15 4/A Esposito Pamela REPL Common Stock S - Sale D 43,5800 -29.273 -1.276 175.994
2021-07-19 2021-01-15 4/A Esposito Pamela REPL Common Stock M - Exercise D 1,0100 29.273 30 205.267
2021-07-19 2021-01-14 4/A Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -20.000 108.203
2021-07-19 2021-01-14 4/A Esposito Pamela REPL Common Stock S - Sale D 45,0200 -20.000 -900 175.994
2021-07-19 2021-01-14 4/A Esposito Pamela REPL Common Stock M - Exercise D 1,0100 20.000 20 195.994
2021-07-19 2021-07-15 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -4.600 68.603
2021-07-19 2021-07-15 4 Esposito Pamela REPL Common Stock S - Sale D 33,3700 -4.600 -154 210.159
2021-07-19 2021-07-15 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 4.600 5 214.759
2021-07-16 2021-07-15 4 Love Colin REPL Common Stock S - Sale D 32,0200 -30.000 -961 835.809
2021-07-07 2021-07-02 4 Coffin Robert REPL Common Stock S - Sale D 40,0400 -7.810 -313 1.775.684
2021-06-30 2021-06-29 4 Coffin Robert REPL Common Stock S - Sale D 40,0500 -22.826 -914 1.783.494
2021-06-30 2021-06-28 4 Coffin Robert REPL Common Stock S - Sale D 40,0400 -14.663 -587 1.806.320
2021-06-16 2021-06-15 4 Love Colin REPL Common Stock S - Sale D 34,5300 -12.200 -421 865.809
2021-06-16 2021-06-15 4 Love Colin REPL Common Stock S - Sale D 33,8000 -17.800 -602 878.009
2021-05-11 2021-05-10 4 Lewis Tanya REPL Employee Stock Option (right to buy) A - Award D 33,99 110.000 110.000
2021-05-11 2021-05-10 4 Lewis Tanya REPL Common Stock A - Award D 73.333 73.333
2021-05-05 2021-05-03 4 Patel Sushil REPL Employee Stock Option (right to buy) A - Award D 36,75 125.000 125.000
2021-05-05 2021-05-03 4 Patel Sushil REPL Common Stock A - Award D 88.333 88.333
2021-04-19 2021-04-15 4 Love Colin REPL Common Stock S - Sale D 29,9800 -2.700 -81 895.809
2021-04-19 2021-04-15 4 Love Colin REPL Common Stock S - Sale D 30,6900 -27.300 -838 898.509
2021-04-05 2021-04-01 4 Esposito Pamela REPL Employee Stock Option (right to buy) A - Award D 31,58 51.250 51.250
2021-04-05 2021-04-01 4 Esposito Pamela REPL Common Stock A - Award D 34.165 210.159
2021-04-05 2021-04-01 4 Franchi Jean M. REPL Employee Stock Option (right to buy) A - Award D 31,58 69.050 69.050
2021-04-05 2021-04-01 4 Franchi Jean M. REPL Common Stock A - Award D 46.035 46.035
2021-04-05 2021-04-01 4 Pirzkall Andrea REPL Employee Stock Option (right to buy) A - Award D 31,58 30.750 30.750
2021-04-05 2021-04-01 4 Pirzkall Andrea REPL Common Stock A - Award D 20.500 21.500
2021-04-05 2021-04-01 4 Astley-Sparke Philip REPL Employee Stock Option (right to buy) A - Award D 31,58 128.125 128.125
2021-04-05 2021-04-01 4 Astley-Sparke Philip REPL Common Stock A - Award D 85.415 1.340.712
2021-04-05 2021-04-01 4 Coffin Robert REPL Employee Stock Option (right to buy) A - Award D 31,58 115.300 115.300
2021-04-05 2021-04-01 4 Coffin Robert REPL Common Stock A - Award D 76.865 1.820.983
2021-04-05 2021-04-01 4 Rhodes Jason P REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Love Colin REPL Employee Stock Option (right to buy) A - Award D 31,58 58.925 58.925
2021-04-05 2021-04-01 4 Love Colin REPL Common Stock A - Award D 39.285 925.809
2021-04-05 2021-04-01 4 Levitsky Hyam REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Lewis Tanya REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Pucci Paolo REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Slootweg Hugo Alexander REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Weinand Dieter REPL Stock Option (right to buy) A - Award D 31,58 24.750 24.750
2021-04-05 2021-04-01 4 Dhingra Kapil REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) A - Award D 31,58 16.500 16.500
2021-04-05 2021-04-01 4 Omega Fund IV, L.P. REPL Stock Option (Right to Buy) A - Award D 31,58 16.500 16.500
2021-03-17 2021-03-15 4 Love Colin REPL Common Stock S - Sale D 32,6700 -100 -3 886.524
2021-03-17 2021-03-15 4 Love Colin REPL Common Stock S - Sale D 33,2200 -18.518 -615 886.624
2021-03-17 2021-03-15 4 Love Colin REPL Common Stock S - Sale D 34,0600 -11.382 -388 905.142
2021-02-18 2021-02-16 4 Love Colin REPL Common Stock S - Sale D 35,8400 -11.380 -408 916.524
2021-02-18 2021-02-16 4 Love Colin REPL Common Stock S - Sale D 36,6100 -18.620 -682 927.904
2021-02-11 2021-02-08 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,0000 -5.249 -236 5.141.321
2021-01-28 2021-01-26 4 Rhodes Jason P REPL Common Stock S - Sale I 46,1400 -5.558 -256 946.000
2021-01-28 2021-01-26 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 46,0400 -3.393 -156 5.283.682
2021-01-28 2021-01-26 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,3400 -26.957 -1.222 5.287.075
2021-01-26 2021-01-22 4 Coffin Robert REPL Common Stock S - Sale D 43,9900 -29.803 -1.311 1.744.118
2021-01-26 2021-01-22 4 Coffin Robert REPL Common Stock S - Sale D 44,8700 -30.197 -1.355 1.773.921
2021-01-26 2021-01-22 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,0300 -3.269 -147 5.314.032
2021-01-26 2021-01-22 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,0500 -8.090 -364 5.317.301
2021-01-19 2021-01-19 4 Astley-Sparke Philip REPL Common Stock S - Sale D 42,4000 -7.632 -324 1.255.297
2021-01-19 2021-01-19 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,1500 -800 -35 1.262.929
2021-01-19 2021-01-15 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,0200 -9.409 -405 1.263.729
2021-01-19 2021-01-15 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,7100 -6.059 -265 1.273.138
2021-01-19 2021-01-15 4 Astley-Sparke Philip REPL Common Stock S - Sale D 44,9500 -1.100 -49 1.279.197
2021-01-19 2021-01-14 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,0600 -100 -4 1.280.297
2021-01-19 2021-01-14 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,6100 -7.448 -325 1.280.397
2021-01-19 2021-01-14 4 Astley-Sparke Philip REPL Common Stock S - Sale D 44,7800 -17.452 -782 1.287.845
2021-01-19 2021-01-19 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -5.727 73.203
2021-01-19 2021-01-19 4 Esposito Pamela REPL Common Stock S - Sale D 42,3800 -5.127 -217 175.994
2021-01-19 2021-01-19 4 Esposito Pamela REPL Common Stock S - Sale D 43,2400 -600 -26 181.121
2021-01-19 2021-01-19 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 5.727 6 181.721
2021-01-19 2021-01-15 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -29.273 78.930
2021-01-19 2021-01-15 4 Esposito Pamela REPL Common Stock S - Sale D 43,5800 -29.273 -1.276 175.994
2021-01-19 2021-01-15 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 29.273 30 205.267
2021-01-19 2021-01-14 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -20.000 108.203
2021-01-19 2021-01-14 4 Esposito Pamela REPL Common Stock S - Sale D 45,0200 -20.000 -900 175.994
2021-01-19 2021-01-14 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 20.000 20 195.994
2021-01-19 2021-01-19 4 Love Colin REPL Common Stock S - Sale D 42,3800 -7.157 -303 946.524
2021-01-19 2021-01-19 4 Love Colin REPL Common Stock S - Sale D 43,2500 -700 -30 953.681
2021-01-19 2021-01-15 4 Love Colin REPL Common Stock S - Sale D 43,0700 -12.396 -534 954.381
2021-01-19 2021-01-15 4 Love Colin REPL Common Stock S - Sale D 43,8000 -7.547 -331 966.777
2021-01-19 2021-01-15 4 Love Colin REPL Common Stock S - Sale D 45,0100 -2.200 -99 974.324
2021-01-19 2021-01-15 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,1900 -1.916 -87 5.325.391
2021-01-19 2021-01-14 4 Omega Fund IV, L.P. REPL Common Stock S - Sale D 45,0900 -17.664 -796 5.327.307
2021-01-15 2021-01-14 4 Franchi Jean M. REPL Employee Stock Option (right to buy) M - Exercise D 14,08 -14.900 140.000
2021-01-15 2021-01-14 4 Franchi Jean M. REPL Common Stock S - Sale D 44,0000 -600 -26 0
2021-01-15 2021-01-14 4 Franchi Jean M. REPL Common Stock S - Sale D 44,5500 -14.300 -637 600
2021-01-15 2021-01-14 4 Franchi Jean M. REPL Common Stock M - Exercise D 14,0800 14.900 210 14.900
2021-01-15 2021-01-13 4 Franchi Jean M. REPL Employee Stock Option (right to buy) M - Exercise D 14,08 -100 154.900
2021-01-15 2021-01-13 4 Franchi Jean M. REPL Common Stock S - Sale D 44,1900 -100 -4 0
2021-01-15 2021-01-13 4 Franchi Jean M. REPL Common Stock M - Exercise D 14,0800 100 1 100
2020-12-28 2020-12-22 4 Coffin Robert REPL Common Stock S - Sale D 40,0400 -220.000 -8.809 1.804.118
2020-12-28 2020-12-23 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,75 -50.704 32.758
2020-12-28 2020-12-23 4 Esposito Pamela REPL Common Stock M - Exercise D 1,7500 50.704 89 175.994
2020-12-22 2020-12-18 4 Rhodes Jason P REPL Common Stock S - Sale I 41,9500 -265 -11 19.285
2020-12-22 2020-12-18 4 Rhodes Jason P REPL Common Stock S - Sale I 41,9500 -1.042 -44 951.558
2020-12-22 2020-12-18 4 Rhodes Jason P REPL Common Stock S - Sale I 41,9500 -3.012 -126 2.263.627
2020-12-17 2020-12-17 4 Rhodes Jason P REPL Common Stock S - Sale I 42,0000 -697 -29 19.550
2020-12-17 2020-12-17 4 Rhodes Jason P REPL Common Stock S - Sale I 42,0000 -2.785 -117 952.600
2020-12-17 2020-12-17 4 Rhodes Jason P REPL Common Stock S - Sale I 42,0000 -8.053 -338 2.266.639
2020-12-17 2020-12-16 4 Rhodes Jason P REPL Common Stock S - Sale I 42,1300 -766 -32 20.247
2020-12-17 2020-12-16 4 Rhodes Jason P REPL Common Stock S - Sale I 42,1300 -3.060 -129 955.385
2020-12-17 2020-12-16 4 Rhodes Jason P REPL Common Stock S - Sale I 42,1300 -8.849 -373 2.274.692
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0800 -6 -0 21.013
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 43,1200 -30 -1 21.019
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 42,4000 -2.432 -103 21.049
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0800 -24 -1 958.445
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 43,1200 -120 -5 958.469
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 42,4000 -9.710 -412 958.589
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0800 -70 -3 2.283.541
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 43,1200 -349 -15 2.283.611
2020-12-17 2020-12-15 4 Rhodes Jason P REPL Common Stock S - Sale I 42,4000 -28.078 -1.191 2.283.960
2020-12-16 2020-12-14 4 Franchi Jean M. REPL Employee Stock Option (right to buy) M - Exercise D 14,08 -25.000 155.000
2020-12-16 2020-12-14 4 Franchi Jean M. REPL Common Stock S - Sale D 42,0900 -389 -16 0
2020-12-16 2020-12-14 4 Franchi Jean M. REPL Common Stock S - Sale D 42,8600 -6.755 -290 389
2020-12-16 2020-12-14 4 Franchi Jean M. REPL Common Stock S - Sale D 43,7000 -17.856 -780 7.144
2020-12-16 2020-12-14 4 Franchi Jean M. REPL Common Stock M - Exercise D 14,0800 25.000 352 25.000
2020-12-15 2020-12-11 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 3,30 -12.590 121.691
2020-12-15 2020-12-11 4 Esposito Pamela REPL Common Stock M - Exercise D 3,3000 12.590 42 125.290
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0600 -181 -8 23.481
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 43,5400 -1.855 -81 23.662
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6900 -240 -10 25.517
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0600 -722 -32 968.299
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 43,5400 -7.409 -323 969.021
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6900 -961 -41 976.430
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 44,0600 -2.087 -92 2.312.038
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 43,5400 -21.428 -933 2.314.125
2020-12-14 2020-12-14 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6900 -2.776 -119 2.335.553
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,9200 -205 -9 25.757
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3200 -1.707 -74 25.962
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,9200 -821 -36 977.391
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3200 -6.817 -295 978.212
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,9200 -2.374 -104 2.338.329
2020-12-14 2020-12-11 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3200 -19.712 -854 2.340.703
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 44,3500 -230 -10 27.669
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 43,4800 -750 -33 27.899
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6800 -1.099 -47 28.649
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 44,3500 -917 -41 985.029
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 43,4800 -2.996 -130 985.946
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6800 -4.389 -187 988.942
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 44,3500 -2.653 -118 2.360.415
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 43,4800 -8.666 -377 2.363.068
2020-12-14 2020-12-10 4 Rhodes Jason P REPL Common Stock S - Sale I 42,6800 -12.691 -542 2.371.734
2020-12-11 2020-12-09 4 Love Colin REPL Common Stock S - Sale D 41,9700 -1.000 -42 976.524
2020-12-11 2020-12-09 4 Love Colin REPL Common Stock S - Sale D 43,1000 -13.750 -593 977.524
2020-12-11 2020-12-09 4 Love Colin REPL Common Stock S - Sale D 43,9000 -7.058 -310 991.274
2020-12-11 2020-12-09 4 Love Colin REPL Common Stock S - Sale D 44,8300 -7.492 -336 998.332
2020-12-11 2020-12-09 4 Love Colin REPL Common Stock S - Sale D 45,8200 -700 -32 1.005.824
2020-12-11 2020-12-10 4 Astley-Sparke Philip REPL Common Stock S - Sale D 42,3900 -3.863 -164 1.305.297
2020-12-11 2020-12-10 4 Astley-Sparke Philip REPL Common Stock S - Sale D 42,9900 -16.051 -690 1.309.160
2020-12-11 2020-12-10 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,7200 -5.086 -222 1.325.211
2020-12-11 2020-12-09 4 Astley-Sparke Philip REPL Common Stock S - Sale D 42,0300 -800 -34 1.330.297
2020-12-11 2020-12-09 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,0900 -11.116 -479 1.331.097
2020-12-11 2020-12-09 4 Astley-Sparke Philip REPL Common Stock S - Sale D 43,8800 -6.459 -283 1.342.213
2020-12-11 2020-12-09 4 Astley-Sparke Philip REPL Common Stock S - Sale D 44,8500 -6.025 -270 1.348.672
2020-12-11 2020-12-09 4 Astley-Sparke Philip REPL Common Stock S - Sale D 45,7900 -600 -27 1.354.697
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 45,3200 -151 -7 29.748
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 44,6900 -635 -28 29.899
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3600 -1.549 -67 30.534
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 42,5100 -151 -6 32.083
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 46,4700 -100 -5 993.331
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 45,3200 -604 -27 993.431
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 44,6900 -2.535 -113 994.035
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3600 -6.183 -268 996.570
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 42,5100 -603 -26 1.002.753
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 45,3200 -1.747 -79 2.384.425
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 44,6900 -7.330 -328 2.386.172
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 43,3600 -17.883 -775 2.393.502
2020-12-09 2020-12-09 4 Rhodes Jason P REPL Common Stock S - Sale I 42,5100 -1.745 -74 2.411.385
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,9400 -2.869 -135 32.234
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,0200 -606 -28 35.103
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,8900 -45.027 -2.111 1.003.356
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,1400 -19.620 -905 1.048.383
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,9400 -33.133 -1.555 2.413.130
2020-12-09 2020-12-08 4 Rhodes Jason P REPL Common Stock S - Sale I 46,0200 -7.001 -322 2.446.263
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 46,9100 -106 -5 35.709
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 45,9700 -2.007 -92 35.815
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 45,4600 -748 -34 37.822
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 46,9300 -2.322 -109 1.068.003
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 46,0600 -26.713 -1.230 1.070.325
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 45,4500 -2.962 -135 1.097.038
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 46,9100 -1.222 -57 2.453.264
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 45,9700 -23.174 -1.065 2.454.486
2020-12-09 2020-12-07 4 Rhodes Jason P REPL Common Stock S - Sale I 45,4600 -8.636 -393 2.477.660
2020-12-09 2020-12-07 4 Dhingra Kapil REPL Stock Option (right to buy) M - Exercise D 1,75 -40.000 3.169
2020-12-09 2020-12-07 4 Dhingra Kapil REPL Common Stock S - Sale D 47,0400 -1.802 -85 0
2020-12-09 2020-12-07 4 Dhingra Kapil REPL Common Stock S - Sale D 46,2200 -13.523 -625 1.802
2020-12-09 2020-12-07 4 Dhingra Kapil REPL Common Stock S - Sale D 45,0900 -24.675 -1.113 15.325
2020-12-09 2020-12-07 4 Dhingra Kapil REPL Common Stock M - Exercise D 1,7500 40.000 70 40.000
2020-12-09 2020-12-08 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) M - Exercise D 3,30 -5.200 24.640
2020-12-09 2020-12-08 4 SLATTERY JOSEPH P REPL Common stock S - Sale D 46,0000 -5.200 -239 6.667
2020-12-09 2020-12-08 4 SLATTERY JOSEPH P REPL Common Stock M - Exercise D 3,3000 5.200 17 11.867
2020-11-18 2020-11-16 4 Love Colin REPL Common Stock S - Sale D 44,4100 -3.759 -167 1.006.524
2020-11-18 2020-11-16 4 Love Colin REPL Common Stock S - Sale D 45,0400 -10.941 -493 1.010.283
2020-11-18 2020-11-16 4 Love Colin REPL Common Stock S - Sale D 46,4300 -300 -14 1.021.224
2020-11-03 2020-11-02 4 Lewis Tanya REPL Stock Option (right to buy) A - Award D 42,00 33.000 33.000
2020-10-16 2020-10-14 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -16.000 128.203
2020-10-16 2020-10-14 4 Esposito Pamela REPL Common Stock S - Sale D 35,0400 -9.000 -315 112.700
2020-10-16 2020-10-14 4 Esposito Pamela REPL Common Stock S - Sale D 30,1500 -7.000 -211 121.700
2020-10-16 2020-10-14 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 16.000 16 128.700
2020-09-17 2020-09-15 4 Atlas Venture Fund X, L.P. REPL Common Stock J - Other D -445.339 2.486.296
2020-09-17 2020-09-15 4 Love Colin REPL Common Stock S - Sale D 24,8300 -1.529 -38 1.021.524
2020-09-17 2020-09-15 4 Love Colin REPL Common Stock S - Sale D 24,1100 -10.271 -248 1.023.053
2020-09-17 2020-09-15 4 Love Colin REPL Common Stock S - Sale D 23,0900 -3.200 -74 1.033.324
2020-09-01 2020-08-31 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,01 -5.000 144.203
2020-09-01 2020-08-31 4 Esposito Pamela REPL Common Stock S - Sale D 27,0500 -5.000 -135 112.700
2020-09-01 2020-08-31 4 Esposito Pamela REPL Common Stock M - Exercise D 1,0100 5.000 5 117.700
2020-08-18 2020-08-17 4 Love Colin REPL Common Stock S - Sale D 23,1900 -5.964 -138 1.036.524
2020-08-18 2020-08-17 4 Love Colin REPL Common Stock S - Sale D 23,6000 -9.036 -213 1.042.488
2020-07-22 3 Pirzkall Andrea REPL Common Stock I 2.000
2020-07-22 3 Pirzkall Andrea REPL Common Stock I 2.000
2020-07-22 3 Pirzkall Andrea REPL Common Stock I 2.000
2020-07-22 2020-07-20 4 Pirzkall Andrea REPL Employee Stock Option (right to buy) A - Award D 22,45 300.000 300.000
2020-07-10 2020-07-09 4 Coffin Robert REPL Common Stock S - Sale D 21,0200 -24.250 -510 2.024.118
2020-07-10 2020-07-09 4 Coffin Robert REPL Common Stock S - Sale D 22,3200 -145.500 -3.248 2.048.368
2020-07-07 2020-07-02 4 Atlas Venture Fund X, L.P. REPL Common Stock J - Other D -445.339 2.931.635
2020-06-18 2020-06-16 4 Atlas Venture Fund X, L.P. REPL Common Stock J - Other D -445.339 3.376.974
2020-04-03 2020-04-01 4 Omega Fund IV, L.P. REPL Stock Option (Right to Buy) A - Award D 9,78 16.500 16.500
2020-04-02 2020-04-01 4 Astley-Sparke Philip REPL Employee Stock Option (right to buy) A - Award D 9,78 265.000 265.000
2020-04-02 2020-04-01 4 Coffin Robert REPL Employee Stock Option (right to buy) A - Award D 9,78 265.000 265.000
2020-04-02 2020-04-01 4 Dhingra Kapil REPL Stock Option (right to buy) A - Award D 9,78 16.500 16.500
2020-04-02 2020-04-01 4 Pucci Paolo REPL Stock Option (right to buy) A - Award D 9,78 33.000 33.000
2020-04-02 2020-04-01 4 Levitsky Hyam REPL Stock Option (right to buy) A - Award D 9,78 16.500 16.500
2020-04-02 2020-04-01 4 Rhodes Jason P REPL Stock Option (right to buy) A - Award D 9,78 16.500 16.500
2020-04-02 2020-04-01 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) A - Award D 9,78 24.249 24.249
2020-04-02 2020-04-01 4 Slootweg Hugo Alexander REPL Stock Option (right to buy) A - Award D 9,78 16.500 16.500
2020-04-02 2020-04-01 4 Weinand Dieter REPL Stock Option (right to buy) A - Award D 9,78 24.750 24.750
2020-04-02 2020-04-01 4 Franchi Jean M. REPL Employee Stock Option (right to buy) A - Award D 9,78 56.350 56.350
2020-04-02 2020-04-01 4 Love Colin REPL Employee Stock Option (right to buy) A - Award D 9,78 116.550 116.550
2020-04-02 2020-04-01 4 Esposito Pamela REPL Employee Stock Option (right to buy) A - Award D 9,78 85.450 85.450
2020-04-02 2020-04-01 4 GORGOL STEPHEN A REPL Employee Stock Option (right to buy) A - Award D 9,78 66.050 66.050
2020-02-24 2020-02-20 4 Coffin Robert REPL Common Stock S - Sale D 17,0400 -24.250 -413 2.193.868
2020-02-14 2020-02-12 4 Coffin Robert REPL Common Stock S - Sale D 17,0300 -24.250 -413 2.218.118
2020-02-14 2020-02-12 4 Coffin Robert REPL Common Stock S - Sale D 17,0400 -24.250 -413 2.242.368
2019-12-23 2019-12-20 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,75 -25.700 83.462
2019-12-23 2019-12-20 4 Esposito Pamela REPL Common Stock M - Exercise D 1,7500 25.700 45 112.700
2019-12-19 2019-11-26 4 Kaufman Howard REPL Employee Stock Option (right to buy) M - Exercise D 3,30 -58.067 91.135
2019-12-19 2019-11-26 4 Kaufman Howard REPL Common Stock M - Exercise D 3,3000 58.067 192 58.067
2019-12-11 2019-12-09 4 Franchi Jean M. REPL Employee Stock Option (right to buy) A - Award D 14,08 180.000 180.000
2019-11-20 3 Atlas Venture Associates Opportunity I, LLC REPL Common Stock I 2.200.000
2019-11-20 3 Atlas Venture Associates Opportunity I, LLC REPL Common Stock I 2.200.000
2019-11-20 3 Atlas Venture Associates Opportunity I, LLC REPL Common Stock I 2.200.000
2019-11-20 3 Atlas Venture Associates Opportunity I, LLC REPL Common Stock I 2.200.000
2019-11-20 3 Atlas Venture Associates Opportunity I, LLC REPL Common Stock I 2.200.000
2019-11-20 2019-11-18 4 Rhodes Jason P REPL Common Stock P - Purchase I 13,6100 1.100.000 14.971 1.100.000
2019-11-20 2019-11-18 4 Omega Fund IV, L.P. REPL Common Stock P - Purchase D 13,6100 220.000 2.994 5.328.939
2019-11-08 2019-11-06 4 Coffin Robert REPL Common Stock S - Sale D 17,0000 -24.250 -412 2.266.618
2019-11-08 2019-11-06 4 Coffin Robert REPL Common Stock S - Sale D 17,0200 -24.250 -413 2.290.868
2019-11-08 2019-11-06 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0000 -14.500 -246 1.355.297
2019-11-08 2019-11-06 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0200 -14.500 -247 1.369.797
2019-11-08 2019-11-06 4 Love Colin REPL Common Stock S - Sale D 17,0000 -11.250 -191 1.051.524
2019-11-08 2019-11-06 4 Love Colin REPL Common Stock S - Sale D 17,0200 -11.250 -191 1.062.774
2019-11-06 2019-11-04 4 Coffin Robert REPL Common Stock S - Sale D 17,0000 -24.250 -412 2.315.118
2019-11-06 2019-11-04 4 Coffin Robert REPL Common Stock S - Sale D 17,0520 -24.250 -414 2.339.368
2019-11-06 2019-11-04 4 Love Colin REPL Common Stock S - Sale D 17,0000 -11.250 -191 1.074.024
2019-11-06 2019-11-04 4 Love Colin REPL Common Stock S - Sale D 17,0520 -11.250 -192 1.085.274
2019-11-06 2019-11-04 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0000 -14.500 -246 1.384.297
2019-11-06 2019-11-04 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0520 -14.500 -247 1.398.797
2019-11-04 2019-10-31 4 Love Colin REPL Common Stock S - Sale D 17,0000 -11.250 -191 1.096.524
2019-11-04 2019-10-31 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0000 -14.500 -246 1.413.297
2019-11-04 2019-10-31 4 Coffin Robert REPL Common Stock S - Sale D 17,0000 -24.250 -412 2.363.618
2019-09-25 2019-09-23 4 Coffin Robert REPL Common Stock S - Sale D 17,0500 -24.250 -413 2.387.868
2019-09-25 2019-09-23 4 Love Colin REPL Common Stock S - Sale D 17,0500 -11.250 -192 1.107.774
2019-09-25 2019-09-23 4 Astley-Sparke Philip REPL Common Stock S - Sale D 17,0500 -14.500 -247 1.427.797
2019-04-03 2019-04-01 4 Omega Fund IV, L.P. REPL Employee Stock Option (Right to Buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 GORGOL STEPHEN A REPL Employee Stock Option (right to buy) A - Award D 15,50 55.000 55.000
2019-04-03 2019-04-01 4 Kaufman Howard REPL Employee Stock Option (right to buy) A - Award D 15,50 80.500 80.500
2019-04-03 2019-04-01 4 Love Colin REPL Employee Stock Option (right to buy) A - Award D 15,50 78.900 78.900
2019-04-03 2019-04-01 4 Slootweg Hugo Alexander REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 Rhodes Jason P REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 Esposito Pamela REPL Employee Stock Option (right to buy) A - Award D 15,50 75.750 75.750
2019-04-03 2019-04-01 4 Coffin Robert REPL Employee Stock Option (right to buy) A - Award D 15,50 219.300 219.300
2019-04-03 2019-04-01 4 Astley-Sparke Philip REPL Employee Stock Option (right to buy) A - Award D 15,50 153.050 153.050
2019-04-03 2019-04-01 4 Weinand Dieter REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 Levitsky Hyam REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-04-03 2019-04-01 4 Dhingra Kapil REPL Stock Option (right to buy) A - Award D 15,50 13.500 13.500
2019-02-14 2019-02-12 4 Atlas Venture Fund X, L.P. REPL Common Stock J - Other D -631.073 3.822.313
2018-12-17 2018-12-13 4 Esposito Pamela REPL Employee Stock Option (right to buy) M - Exercise D 1,75 -87.000 109.162
2018-12-17 2018-12-13 4 Esposito Pamela REPL Common Stock M - Exercise D 1,7500 87.000 152 87.000
2018-07-26 2018-07-24 4 Bain Capital Life Sciences Investors, LLC See footnotes REPL Series B Convertible Preferred Stock C - Conversion I -235.146 0
2018-07-26 2018-07-24 4 Bain Capital Life Sciences Investors, LLC See Footnotes REPL Common Stock P - Purchase I 15,0000 500.000 7.500 2.838.968
2018-07-26 2018-07-24 4 Bain Capital Life Sciences Investors, LLC See Footnotes REPL Common Stock C - Conversion I 2.338.968 2.338.968
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Series B Convertible Preferred Stock C - Conversion I -1.013.547 0
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Series A Convertible Preferred Stock C - Conversion I -2.579.881 0
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Series Seed Convertible Preferred Stock C - Conversion I -994.688 0
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Warrant (right to buy) C - Conversion I -248.672 0
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Warrant (right to buy) C - Conversion I 248.672 248.672
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Common Stock P - Purchase I 15,0000 133.333 2.000 4.721.449
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Common Stock C - Conversion I 1.013.547 4.588.116
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Common Stock C - Conversion I 2.579.881 3.574.569
2018-07-26 2018-07-24 4 Forbion Capital Fund III Cooperatief U.A. REPL Common Stock C - Conversion I 994.688 994.688
2018-07-26 2018-07-24 4 SLATTERY JOSEPH P REPL Stock Option (right to buy) A - Award D 15,00 13.500 13.500
2018-07-26 2018-07-24 4 SLATTERY JOSEPH P REPL Common Stock P - Purchase D 15,0000 6.667 100 6.667
2018-07-26 2018-07-24 4 Coffin Robert REPL Employee Stock Option (right to buy) A - Award D 15,00 175.000 175.000
2018-07-26 2018-07-24 4 Rhodes Jason P REPL Stock Option (right to buy) A - Award D 15,00 13.500 13.500
2018-07-26 2018-07-24 4 Rhodes Jason P REPL Series B Convertible Preferred Stock C - Conversion I -1.013.547 0
2018-07-26 2018-07-24 4 Rhodes Jason P REPL Series A Convertible Preferred Stock C - Conversion I -3.439.839 0
2018-07-26 2018-07-24 4 Rhodes Jason P REPL Common Stock C - Conversion I 1.013.547 4.453.386
2018-07-26 2018-07-24 4 Rhodes Jason P REPL Common Stock C - Conversion I 3.439.839 3.439.839
2018-07-26 2018-07-24 4 Love Colin REPL Employee Stock Option (right to buy) A - Award D 15,00 100.000 100.000
2018-07-26 2018-07-24 4 GORGOL STEPHEN A REPL Employee Stock Option (right to buy) A - Award D 15,00 35.000 35.000
2018-07-26 2018-07-24 4 Esposito Pamela REPL Employee Stock Option (right to buy) A - Award D 15,00 70.000 70.000
2018-07-26 2018-07-24 4 Levitsky Hyam REPL Stock Option (right to buy) A - Award D 15,00 27.000 27.000
2018-07-26 2018-07-24 4 Kaufman Howard REPL Employee Stock Option (right to buy) A - Award D 15,00 150.000 150.000
2018-07-26 2018-07-24 4 Weinand Dieter REPL Stock Option (right to buy) A - Award D 15,00 27.000 27.000
2018-07-26 2018-07-24 4 Atlas Venture Fund X, L.P. REPL Series B Convertible Preferred Stock C - Conversion D -1.013.547 0
2018-07-26 2018-07-24 4 Atlas Venture Fund X, L.P. REPL Series A Convertible Preferred Stock C - Conversion D -3.439.839 0
2018-07-26 2018-07-24 4 Atlas Venture Fund X, L.P. REPL Common Stock C - Conversion D 1.013.547 4.453.386
2018-07-26 2018-07-24 4 Atlas Venture Fund X, L.P. REPL Common Stock C - Conversion D 3.439.839 3.439.839
2018-07-26 2018-07-24 4 Dhingra Kapil REPL Stock Option (right to buy) A - Award D 15,00 13.500 13.500
2018-07-26 2018-07-24 4 Astley-Sparke Philip REPL Employee Stock Option (right to buy) A - Award D 15,00 140.000 140.000
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Stock Option (right to buy) A - Award D 15,00 13.500 13.500
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Series B Convertible Preferred Stock C - Conversion I -1.013.547 0
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Series A Convertible Preferred Stock C - Conversion I -2.579.881 0
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Series Seed Convertible Preferred Stock C - Conversion I -994.688 0
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Warrant (right to buy) C - Conversion I -248.672 0
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Warrant (right to buy) C - Conversion I 248.672 248.672
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Common Stock P - Purchase I 15,0000 133.333 2.000 4.721.449
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Common Stock C - Conversion I 1.013.547 4.588.116
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Common Stock C - Conversion I 2.579.881 3.574.569
2018-07-26 2018-07-24 4 Slootweg Hugo Alexander REPL Common Stock C - Conversion I 994.688 994.688
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Series B Convertible Preferred Stock C - Conversion D -101.896 0
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Series A Convertible Preferred Stock C - Conversion D -259.366 0
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Series Seed Preferred Stock C - Conversion D -100.000 0
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Common Stock Warrants (right to buy) C - Conversion D 248.672 248.672
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Series Seed Warrants (right to buy) C - Conversion D -25.000 0
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Common Stock C - Conversion D 1.013.547 4.854.783
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Common Stock C - Conversion D 2.579.881 3.841.236
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Common Stock C - Conversion D 994.688 1.261.355
2018-07-25 2018-07-24 4 Omega Fund IV, L.P. REPL Common Stock P - Purchase D 15,0000 266.667 4.000 266.667
2018-07-25 2018-07-19 4 Omega Fund IV, L.P. REPL Common Stock Option A - Award D 15,00 13.500 13.500
2018-07-25 2018-07-24 4 Redmile Group, LLC REPL Series B Convertible Preferred Stock C - Conversion I -78.382 0
2018-07-25 2018-07-24 4 Redmile Group, LLC REPL Common Stock C - Conversion I 779.655 779.655
2018-07-19 3 Astley-Sparke Philip REPL Common Stock D 2.884.594
2018-07-19 3 Astley-Sparke Philip REPL Common Stock D 2.884.594
2018-07-19 3 Astley-Sparke Philip REPL Common Stock D 2.884.594
2018-07-19 3 Coffin Robert REPL Common Stock D 4.824.236
2018-07-19 3 Coffin Robert REPL Common Stock D 4.824.236
2018-07-19 3 Coffin Robert REPL Common Stock D 4.824.236
2018-07-19 3 Love Colin REPL Common Stock D 2.238.048
2018-07-19 3 Love Colin REPL Common Stock D 2.238.048
2018-07-19 3 Love Colin REPL Common Stock D 2.238.048
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:7R8 7,29 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista